Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

The Krainer lab discovered a three-oncogene circuit that helps drive the aggressive progression of pancreatic ductal ...

A new mouse study by researchers at the University of California (UC), San Diego, School of Medicine reveals that an enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal ...

Despite being diagnosed with what he himself referred to as a "death sentence," the former U.S. senator declared that he's ...

Pancreatic ductal adenocarcinoma (PDAC) is both the most common and the deadliest type of pancreatic cancer. Most treatment ...